Characteristics of Pheochromocytoma in a 4‐ to 20‐Year‐Old Population

Abstract:  Hypertension in children and adolescents has become a major health problem recently recognized, and in a significant number of patients it is due to an endocrine tumor. The aim of this study was to establish the characteristics of pheochromocytoma in a population of 58 patients between 4 and 20 years of age studied at our Center. They represented a 23% of the total population of 255 pheochromocytoma patients studied. In the younger group (under 20 years of age), there was a marked predominance of severe sustained hypertension (93%), only 7% presented paroxysmal hypertension and none of them was normotensive. The youngsters studied showed a higher incidence of bilateral adrenal pheochromocytoma (34%) and extra‐adrenal pheochromocytoma (22%). Malignancy was found in 12% of these patients. In addition, the incidence of familial pheochromocytoma was elevated in these patients (39%). Surprisingly, in contrast with the adult population where the most frequent familial pheochromocytomas were multiple endocrine neoplasia (MEN) type 2A (15%), the younger population showed a higher predominance of von Hippel–Lindau (VHL) (28%) and lower incidence of MEN 2A, MEN 2B, neurofibromatosis (NF), and succinate dehydrogenase subunit B (SDHB). In the VHL group, only two patients belonging to one family, showed the R167W mutation, while the others showed novel mutations in conserved amino acids. It may be speculated that the high incidence of VHL in youngsters may account for the biochemical and clinical features they usually present.

[1]  O. Gimm.  Pheochromocytoma-associated syndromes: genes, proteins and functions of RET, VHL and SDHx , 2004, Familial Cancer.

[2]  H. Neumann,et al.  Mutations of the SDHB and SDHD genes , 2004, Familial Cancer.

[3]  N. Abumrad,et al.  Clinical experience over 48 years with pheochromocytoma. , 1999, Annals of surgery.

[4]  A. Vortmeyer,et al.  Genetic aspects of pheochromocytoma. , 2001, Endocrine regulations.

[5]  W. Mcdougal.  Pheochromocytoma: state-of-the-art and future prospects. , 2005, The Journal of urology.

[6]  D. Goldstein,et al.  Determination of metanephrines in plasma by liquid chromatography with electrochemical detection. , 1993, Clinical chemistry.

[7]  C. Troidl,et al.  SDHC mutations in hereditary paraganglioma/pheochromocytoma , 2004, Familial Cancer.

[8]  J. Ross,et al.  Pheochromocytoma. Special considerations in children. , 2000, The Urologic clinics of North America.

[9]  A. Parra,et al.  Urinary excretion of catecholamines in healthy subjects in relation to body growth. , 1980, Acta endocrinologica.

[10]  W. Neblett,et al.  Twenty-Five-Year Surgical Experience with Pheochromocytoma in Children , 2000, The American surgeon.

[11]  E. Levine,et al.  Familial pheochromocytomas with unusual associations. , 1992, Journal of pediatric surgery.

[12]  M. Barontini,et al.  Familial isolated pheochromocytoma presenting a new mutation in the von Hippel-Lindau gene. , 2004, American journal of hypertension.

[13]  D. Murphy,et al.  Simultaneous liquid-chromatographic determination of 3,4-dihydroxyphenylglycol, catecholamines, and 3,4-dihydroxyphenylalanine in plasma, and their responses to inhibition of monoamine oxidase. , 1986, Clinical chemistry.

[14]  Z. Y. Xue,et al.  [Pheochromocytoma in children]. , 1987, Zhonghua wai ke za zhi [Chinese journal of surgery].

[15]  E. Bravo.  Pheochromocytoma: current perspectives in the pathogenesis, diagnosis, and management. , 2004, Arquivos brasileiros de endocrinologia e metabologia.

[16]  I NASSO.  [Pheochromocytoma in childhood]. , 1955, Minerva medica.

[17]  S. Sheps,et al.  Pheochromocytoma in the pediatric age group: current status. , 1983, Journal of pediatric surgery.

[18]  C. Scaroni,et al.  Clinical and Genetic Aspects of Phaeochromocytoma , 2003, Hormone Research in Paediatrics.

[19]  J. Pisano,et al.  Determination of 3-methoxy-4-hydroxymandelic acid in urine. , 1962, Clinica chimica acta; international journal of clinical chemistry.

[20]  I. Ilias,et al.  Biochemical diagnosis, localization and management of pheochromocytoma: focus on multiple endocrine neoplasia type 2 in relation to other hereditary syndromes and sporadic forms of the tumour , 2005, Journal of internal medicine.

[21]  K. Newman,et al.  The Diagnosis and Management of Endocrine Tumors Causing Hypertension in Children , 2002, Annals of the New York Academy of Sciences.

[22]  F. Mantero,et al.  Pheochromocytoma in von Hippel–Lindau disease and neurofibromatosis type 1 , 2004, Familial Cancer.

[23]  M. Walther,et al.  Biochemical diagnosis of pheochromocytoma: which test is best? , 2002, JAMA.